Supplementary Tables S1-S3 from STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic Drugs

Abstract

<p>Pre- and Post-therapeutically staged tumors according to the International Federation of Gynecology and Obstetrics or TNM categories (S1); List of used antibodies (S2); Primers for amplification of cDNAs of IRF1 and IRF2 (S3).</p>